• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
    Elinzanetant
    |
    Weekly News Recap #Phispers Elinzanetant
    Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

    Pfizer, Novo escalate bidding war for obesity-drug developer Metsera; Kimberly-Clark to buy Kenvue for US$ 48.7 bn

    As we return from our one-week break due to the CPhI Worldwide, we find our double-dose Phispers edition to be filled with se...

    Impressions : 1455

    Astra targets US$ 80 bn revenue by 2030, invests US$ 1.5 bn in ADC plant; Lilly’s weekly insulin scores late-stage wins

    Astra targets US$ 80 bn revenue by 2030, invests US$ 1.5 bn in ADC plant; Lilly’s weekly insulin scores late-stage wins

    In this week’s news, AstraZeneca has laid out an ambitious plan to achieve US$ 80 billion in revenue by 2030. The drugmak...

    Impressions : 1036

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.